Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

11/15/2013 | 10:34pm US/Eastern

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
carolyn@burzynskiclinic.com


© Business Wire 2013
Latest news
Date Title
<1m ago TETRAGON FIN GRP : Financial Group Limited (TFG) Monthly Update for September 2014
<1m ago YOKOGAWA ELECTRIC : Financial Results for 1st Half of Fiscal Year 2014 (PDF: 298KB/12P)
<1m ago YOKOGAWA ELECTRIC : Revision of Financial and Dividend Forecast for Fiscal Year 2014 (PDF: 87KB/2P)
<1m ago YOKOGAWA ELECTRIC : Industrial Automation - Solutions Service Business - (PDF: 793KB/10P)
<1m ago URANIUM EQUITIES : Lapse of Unlisted Performance Rights
<1m ago CHROMA ATE : Reports Year 2014 Third Quarter Financial Results - Third Quarter EPS Reached NTD 1.30, Growth of 48% QoQ and 78% YoY
<1m ago LIMITLESS EARTH : Half-yearly Report
<1m ago AQUARIUS PLATINUM LIMITED - Annual Report 2014
<1m ago ELEMENTIS : Interim Management Statement
<1m ago SES : Q3 2014 Results
Latest news
Advertisement
Hot News 
NATIONAL EXPRESS : accelerates after passenger rise
AFREN : takes hit in third quarter
EQUINIX : to Attend NAREIT REITWorld 2014 Conference (MEDIA ALERT)
DEUTSCHE LUFTHANSA : Lufthansa cuts 2015 forecast on global economic slowdown
ADDUS HOMECARE : posts 3Q profit
Most Read News
1d ago CHINA MENGNIU DAIRY : Mengniu and Danone Strengthen Strategic Alliance as Danone Subscribes to a Private Placement by Yashili
1d ago ENERGEN : tops Street 3Q forecasts
1d ago Hiring business drives LinkedIn's revenue beat
1d ago Starbucks Americas sales disappoint on softer traffic
1d ago FLUOR NEW : ICA Fluor Awarded Fabrication Contract for Shell’s Heavy Oil Extraction Project in Canada
Most recommended articles
2m ago Japan shares soar, yen skids after BOJ stuns with new easing steps
2m ago Japan shares soar, yen skids after BOJ stuns with new easing steps
4m ago BOJ Governor Kuroda comments at news conference
5m ago BOJ shocks markets with more easing as inflation slows
5m ago BOJ shocks markets with more easing as inflation slows
Dynamic quotes  
ON
| OFF